People

Search Language

Deutsch / German | Use language selector above (below, on mobile) to search additional languages

See by

close filter
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  • Search
  • Selected filters
  • x(r)

83 items matching filters

Search Results

450076

Practice:

  • Geistiges Eigentum
  • Patents
  • Life Sciences & HealthTech
  • Supreme Court & Appellate

Irena Royzman, Ph.D. Partner

New York

With a Ph.D. in biology from MIT and the Whitehead Institute, where she was a NSF fellow, Irena represents plaintiffs and defendants in their most complex pharmaceutical and biotech patent cases. Over the last 20 years, pharmaceutical and biotechnology innovators have relied on Irena again and again for cases involving small molecules, biologics, recombinant DNA technology, gene therapy, gene editing, manufacturing processes, formulations and drug-eluting medical devices, including numerous multi-billion dollar cases involving many of the world’s best-selling drugs.

Irena has significant experience in litigation under the Hatch-Waxman Act (ANDA and 505(b)(2) actions) and the Biologics Price Competition and Innovation Act (BPCIA), as well as inter partes review (IPR) proceedings, license disputes and matters with parallel ex-U.S. litigation and proceedings in foreign patent offices. Irena also helps life sciences companies and organizations develop the law in the most important cases for the biopharma industry. She has been principal counsel on numerous amicus briefs to the United States Supreme Court and the Federal Circuit in key biopharma cases.

For plaintiffs, Irena has successfully defended generic challenges to patents protecting blockbuster medical therapies, including multi-billion dollar cancer, antiviral, diabetes and anti-psychotic drugs, including recently obtaining attorneys’ fees in a hard-fought ANDA action. She also represents innovators in biosimilar litigation from its outset, including in some of the first cases under the BPCIA involving antibodies. Irena also represents clients in innovator vs innovator disputes. For defendants, she defeated a $530 million claim of patent infringement of a competitor’s biotech patent, obtaining dismissal of all claims and discovery sanctions against the patent owner. In another high-stakes case, she obtained summary judgment of noninfringement and exclusion of plaintiff’s experts under Daubert as well as a full award of attorneys’ fees. A registered patent attorney, Irena also handles inter partes review (IPR) proceedings. For patent owners, she has obtained denial of IPR for patents protecting blockbuster drugs and has leveraged IPR for defendants to obtain freedom to operate.

Irena also coordinates U.S. proceedings with parallel ex-U.S. litigation and proceedings in foreign patent offices, recently obtaining freedom to operate for a biotech innovator’s gene therapy. She provides strategic counseling in biologics and pharmaceuticals and advises clients on their IP portfolios and transactions. Irena also represents clients in high-stakes license disputes involving biotech patents, and, in a dispute concerning the use of a recombinant protein as an enzyme replacement therapy, obtained one of the largest settlement awards over the life of the contract.

Chambers USA has recognized Irena as a leading lawyer in intellectual property, where clients have described her as “excellent,” “knowledgeable, aggressive,” “knows the science forward and backward” and “an incredibly smart lawyer.” Benchmark Litigation named her one of the “Top 250 Women in Litigation” for the last eight years and a litigation star in intellectual property. Irena was also named to the Crain’s New York Business list of “Notable Women in Law.” She is also recognized as a leading lawyer by Legal 500. Irena writes and lectures widely on biopharma patent issues and biosimilar litigation. Irena also is frequently quoted on patent-related issues, including in the Washington Post, Financial Times, Nature Biotechnology, Bloomberg and Pink Sheet.

740

Practice:

  • Supreme Court & Appellate

Daniel A. Rubens Partner

New York

Danny's practice focuses on appellate litigation. He has led the drafting on dozens of appellate briefs, and regularly argues appeals in state and federal courts. Danny has extensive trial litigation experience as well, with an emphasis on dispositive motions, preserving appellate issues, and developing creative legal strategies.

Danny’s work has covered a wide range of subject areas, including securities, bankruptcy, intellectual property, arbitration, class actions, and criminal law. He has a deep understanding of appeals and critical motions in financial services litigation, and in recent years has played a key role in representing financial institutions in major RMBS cases brought by trustees, investors, and monoline insurers. His financial services clients include Credit Suisse, Goldman Sachs, Mr. Cooper, and Ocwen. He also represents leading technology companies in precedent-setting cases involving antitrust law and ballot initiatives, as well as other complex commercial litigation.  In addition, Danny is an experienced bankruptcy litigator, having represented various debtors and creditors in fraudulent transfer cases and other contested insolvency-related matters involving U.S. and foreign law.

Danny is a member of the Second Circuit's pro bono panel and maintains an active pro bono practice focusing on criminal, immigration, racial justice, and LGBTQ+ rights matters in the Supreme Court and other appellate courts. He was recently recognized by the National LGBTQ+ Bar Association as a “Best LGBTQ+ Lawyer Under 40,” by the New York Law Journal as a Rising Star, and by LawDragon in its inaugural 500 X – The Next Generation listing.  As part of his commitment to diversity, equity, and inclusion, Danny serves as a mentor for The Appellate Project, an organization focused on empowering law students of color to thrive in the appellate field. He has also served as an Orrick ambassador for the Move The Needle Fund, a collaborative effort designed by Diversity Lab to create a more diverse and inclusive legal profession.

Before joining Orrick, Danny served as a law clerk to U.S. Supreme Court Justice Ruth Bader Ginsburg, Judge Robert A. Katzmann of the U.S. Court of Appeals for the Second Circuit, and Judge Jed S. Rakoff of the U.S. District Court for the Southern District of New York. Following his clerkships, he was selected to represent the American Inns of Court as a Temple Bar Scholar in London.

Practice:

  • Technology Companies Group
  • Mergers & Acquisitions

Dr. Johannes Rüberg, EMBA Partner

München

Dies umfasst Venture- und Wachstumsfinanzierungen in allen Phasen sowie die allgemeine gesellschaftsrechtliche Beratung. Ein weiterer Schwerpunkt seiner Tätigkeit ist die Beratung von strategischen und Finanzinvestoren bei Fusionen und Übernahmen.

Im JUVE Handbuch (2024/2025) wird Johannes Rüberg als oft empfohlen für Gesellschaftsrecht sowie für Venture Capital geführt, einschließlich des Zitats "sehr gute Fachkenntnisse, angenehme Zusammenarbeit" eines Wettbewerbers. Legal 500 Deutschland führt ihn als "empfohlener Anwalt" für Venture Capital (2024) und veröffentlichte in der Ausgabe 2022 die Testimonials „sehr unterstützend und angenehm in der Zusammenarbeit“, „äußerst gewissenhaft“ und „schnelle Reaktionszeit“. Vom Handelsblatt ist er seit 2021 in der Kategorie „Anwälte der Zukunft“ für Gesellschaftsrecht ausgezeichnet.

Neben seiner anwaltlichen Tätigkeit hat Johannes Rüberg das Kellogg-WHU-Executive-MBA-Programm abgeschlossen.

Practice:

  • Komplexe Streitfälle & Streitbeilegung
  • Securities Litigation
  • Mass Torts & Product Liability

Aaron M. Rubin Partner

Orange County

An accomplished litigator, Aaron advises leading investment banks, financial institutions, mortgage servicers, non-bank lenders, and alternative asset managers on the unique issues impacting the finance sector, from major commercial disputes to securities litigation and enforcement actions. Leveraging his dispute resolution expereince, Aaron serves as a trusted partner to clients, advising on best practices for mitigating risk long before there is the threat of litigation.

In 2018, Aaron moved to the firm’s Orange County office from New York. The move served his New York-based traditional financial institution clients needing counsel on the West Coast, while also expanding his practice.

740

Practice:

  • Mergers & Acquisitions
  • Capital Markets
  • Lateinamerika
  • Life Sciences & HealthTech

David M. Ruff Partner

New York

David advises private equity funds, their portfolio companies and a broad range of public and private technology, energy and life sciences companies in domestic and cross-border M&A, minority and majority investments, joint ventures and other complex transactions.
740

Practice:

  • Finance Sector
  • White Collar, Investigations, Securities Litigation & Compliance
  • Wertpapierrechtsstreitigkeiten, Sammelklagen und Aktionärsklagen
  • Financial Services Litigation
  • Behördliche Untersuchungen und Vollstreckungsmaßnahmen
  • Interne Revision

Paul F. Rugani Partner

Orange County; New York; Seattle

Legal 500 touts Paul as a recommended attorney for Securities Litigation, observing that he is “among the most creative and strategic lawyers” who always has “an eye on the end game.”  Paul achieved American Lawyer Litigator of the Week recognition as part of a team that achieved a ground-breaking New York Court of Appeals victory that substantially reduced financial exposure in RMBS repurchase litigation.

Leader of Orrick's Securities Litigation practice and deputy leader of the Firm's Financial Services Litigation practice, Paul has extensive experience representing clients in securities class actions, shareholder derivative lawsuits, commercial contractual disputes and other complex litigation matters at both the trial and appellate levels, as well as in connection with internal, government and regulatory investigations. Paul also counsels domestic and foreign accounting firms on matters related to state CPA licensing and state board regulation.

740

Practice:

  • Technology & Innovation Sector

Michael Ruiz Partner

Silicon Valley; Seattle

Michael advises his clients on a broad range of legal needs, including corporate formation and structure, venture capital financings, board and stockholder relationships and exit transactions. His current and former clients are concentrated in interactive media industries including game development, Esports, AR/VR tech, 3D animation, and artificial intelligence. Michael also advises companies in the cleantech and life sciences sectors.

His favorite video game is Final Fantasy (VII), favorite board game is Twilight Imperium (IV) and favorite science fiction book is Ender’s Game.

Noah Rushin Associate

Washington, D.C.

Noah brings a detail-oriented and analytical approach to complex technical disputes. He has conducted prior art searches, analyzed chemical compositions and manufacturing processes, and drafted detailed infringement and invalidity contentions. Noah’s experience includes preparing expert reports, post-hearing briefs, and trial demonstratives, as well as developing deposition strategies and second-chairing depositions. He has participated in two trials before the International Trade Commission, assisting with examination outlines and trial exhibit negotiations.

Noah earned his J.D. from Columbia Law School, where he served as an editor of the Columbia Science and Technology Law Review. He holds a B.S. in Chemical Engineering, with distinction, from the University of Virginia, where he was a Rodman Scholar. His technical expertise is complemented by proficiency in Matlab, SQL, and other analytical tools. Noah is admitted to practice in New York and Washington, D.C.

Zoe Russell Managing Associate

Los Angeles

Zoe works on diverse employment litigation matters. She is also active in pro bono matters.

Zoe received her J.D. from the University of California, Los Angeles School of Law, where she simultaneously earned her M.A. in African American Studies. While in law school, she served as the Co-Chair for the Black Law Students Association and the Director of Affordable Housing for the UCLA Graduate Students Association.

740

Practice:

  • Technology & Innovation Sector
  • Geistiges Eigentum
  • Trademark, Copyright & Media
  • Trade Secrets Litigation
  • Artificial Intelligence (AI)
  • Patents
  • Komplexe Streitfälle & Streitbeilegung

Diana M. Rutowski Partner

Silicon Valley

As a seasoned IP litigator and counselor, Diana’s practice has run the gamut from high stakes trials, to take-down and anti-counterfeiting campaigns, to employee departure and trade secret investigations. She represents clients in District and state courts and before administrative bodies including the ITC and the USPTO. For example, Diana tried and won a complex case in which the other side sought to extend the monopoly of an expired utility patent by claiming trade dress rights in a technical product feature. Drawing upon experience handling both complex patent and trademark matters, her team successfully argued that the intersection of patent and trademark policy prevented the other side from continuing its monopoly, clearing the way for her client to enter the market. With Diana at their side, companies can rest assured that their essential assets are protected, from their core technologies, to assets including their company name, logo, and website.

While at Orrick, Diana was seconded to the City and County of San Francisco, where she had the privilege to serve as an Assistant District Attorney, and first-chair several trials. She was also seconded to Salesforce, where she learned first-hand that the law comprises just one component of a company’s overall business strategy.

Diana is also passionate about her pro bono work. For example, she represented two detainees in Guantanamo in connection with their petitions for a writ of habeas corpus, and she is currently working with the Lawyers’ Committee for Civil Rights of the San Francisco Bay Area. Before joining the firm, Diana worked for the Legal Aid of Cambodia where she assisted with the prosecution of former Khmer Rouge officials and represented individuals who sought to reclaim land rights.

Diana is a member of the International Trademark Association, of ChIPs: Advancing Women in IP and of the Harvard Club of San Francisco.

431513

Practice:

  • Financial & Fintech Advisory
  • Strategic Advisory & Government Enforcement (SAGE)
  • Fintech

Kathryn Ryan Partner

Washington, D.C.

She represents banks, first and second mortgage originators and servicers, reverse mortgage originators and servicers, fulfillment service providers, commercial lenders and servicers, bank holding companies, private equity firms, finance companies, debt collection companies, financial institutions and technology companies, payment processors, money transmitters and various related service providers.

Katy assists clients with matters before state regulatory agencies, the Consumer Financial Protection Bureau (CFPB), the Department of Justice (DOJ), the Department of Housing and Urban Development (HUD), federal banking agencies, Fannie Mae and Freddie Mac. She also provides strategic and tactical advice to help clients identify and secure the nationwide federal and state approvals necessary to achieve operational goals.

Prior to joining Orrick, Katy was a partner at Buckley LLP, where she was a member of the firm’s partner board.